脑胰岛素信号、阿尔茨海默病病理与认知功能
该临床-病理学研究基于社区队列宗教修会研究,纳入150例死亡时平均87岁的个体(75例糖尿病与75例非糖尿病按性别、死亡年龄和教育匹配),评估死后额中回皮质胰岛素信号与AD病理及认知的关联。结果显示AKT磷酸化与整体AD病理评分相关,且pT308 AKT1与淀粉样蛋白负荷、tau缠结密度正相关并与整体认知功能较低相关;IRS1磷酸化与AD无关。
要点
- 脑AKT磷酸化与AD病理评分相关(p=0.001)。
- pT308 AKT1与淀粉样蛋白负荷和tau缠结密度正相关。
- pT308 AKT1与较低整体认知功能相关(估计值-0.212,P=0.031)。
核心结论
- 脑AKT磷酸化作为胰岛素及其他生长因子信号的关键节点,与AD神经病理和较低认知功能相关。
研究设计与样本
- 临床-病理学研究,源于社区队列宗教修会研究,纳入150例个体(死亡时平均年龄87岁,48%女性),75例糖尿病与75例非糖尿病按性别、死亡年龄和教育匹配。
- 采用酶联免疫吸附测定、免疫组化和离体脑组织胰岛素刺激评估死后额中回皮质胰岛素信号,死后数据记录AD神经病理,临床评估基于17项神经心理学测试记录临近死亡时认知功能。
主要发现
- 糖尿病与非糖尿病者脑IRS1磷酸化(pS307 IRS1/总IRS1)和AKT磷酸化(pT308 AKT1/总AKT1)相似。
- AKT磷酸化与整体AD病理评分相关(p=0.001),而IRS1磷酸化与AD无关(p=0.536)。
- 未发现胰岛素信号与整体AD评分的其他关联,包括使用离体脑胰岛素刺激方法时。
- 二次分析中,归一化pT308 AKT1与淀粉样蛋白负荷和tau缠结密度均正相关,未观察到脑胰岛素信号与神经病理的其他关联。
- 归一化pT308 AKT1与较低整体认知功能相关(估计值=-0.212,标准误=0.097;p=0.031)。
临床怎么用
- 脑AKT磷酸化可能作为连接AD病理与认知功能的信号节点,但当前为关联性发现,尚不能用于临床诊断或治疗决策。
局限性
- 研究为观察性临床-病理学设计,不能推断因果关系。
- 样本来自特定社区队列(宗教修会研究),外推性需谨慎。
- 仅评估额中回皮质胰岛素信号,未覆盖其他脑区。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine associations of molecular markers of brain insulin signaling with Alzheimer disease (AD) and cognition among older persons with or without diabetes. METHODS: This clinical-pathologic study was derived from a community-based cohort study, the Religious Orders Study. We studied 150 individuals (mean age at death =87 years, 48% women): 75 with and 75 without diabetes (matched by sex on age at death and education). Using enzyme-linked immunosorbent assay, immunohistochemistry, and ex vivo stimulation of brain tissue with insulin, we assessed insulin signaling in the postmortem middle frontal gyrus cortex. Postmortem data documented AD neuropathology. Clinical evaluations documented cognitive function proximate to death, based on 17 neuropsychological tests. In adjusted regression analyses, we examined associations of brain insulin signaling with diabetes, AD, and level of cognition. RESULTS: Brain insulin receptor substrate-1 (IRS1) phosphorylation (pS307 IRS1/total IRS1) and serine/threonine-protein kinase (AKT) phosphorylation (pT308 AKT1/total AKT1) were similar in persons with or without diabetes. AKT phosphorylation was associated with the global AD pathology score (p = 0.001). In contrast, IRS1 phosphorylation was not associated with AD (p = 0.536). No other associations of insulin signaling were found with the global AD score, including when using the ex vivo brain insulin stimulation method. In secondary analyses, normalized pT308 AKT1 was positively correlated with both the amyloid burden and tau tangle density, and no other associations of brain insulin signaling with neuropathology were observed. Moreover, normalized pT308 AKT1 was associated with a lower level of global cognitive function (estimate = -0.212, standard error = 0.097; p = 0.031). INTERPRETATION: Brain AKT phosphorylation, a critical node in the signaling of insulin and other growth factors, is associated with AD neuropathology and lower cognitive function. ANN NEUROL 2020;88:513-525.
引用
- Arvanitakis Z, Wang HY, Capuano AW, et al. Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function. Ann Neurol. 2020. PMID: 32557841. doi:10.1002/ana.25826
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。